Kintsugi

About:

Kintsugi detects signs of clinical depression and anxiety using machine learning and voice biomarkers.

Top Investors: Techstars, National Science Foundation, AngelList, On Deck, Insight Partners

Description:

Kintsugi is developing novel voice biomarker software to detect signs of depression and anxiety from short clips of free form speech. Awarded multiple distinctions for AI technology and recently named one of Forbes’ Top 50 AI companies to watch in 2022, Kintsugi helps to close mental health care gaps across risk-bearing health systems, ultimately saving time and lives.

Total Funding Amount:

$30.9M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2019-01-01

Contact Email:

hello(AT)kintsugihealth.com

Founders:

Grace Chang, Rima Seiilova-Olson

Number of Employees:

11-50